Organ-sparing treatment in muscle-invasive bladder cancer

Strahlentherapie und Onkologie

Volumn 181, Issue 10, 2005, Pages 632-637

  Dunst, Jürgen ^a,d   Diestelhorst, Andrea ^a   Kühn, Reinhard ^b   Müller, Arndt Christian ^a   Scholz, Hans Jörg ^c   Fornara, Paolo ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Martha Maria Hospital Halle   (Germany)

^c Asklepios Hospital Weißenfels   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Bladder cancer; Chemotherapy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PACLITAXEL;

ADULT; AGE DISTRIBUTION; AGED; ALLERGIC REACTION; ANEMIA; ARTICLE; BLADDER CANCER; BLADDER DYSFUNCTION; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTECTOMY; CYSTITIS; CYSTOSCOPY; DIARRHEA; ENTERITIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MUSCLE METASTASIS; NAUSEA; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; SKIN MANIFESTATION; TRANSURETHRAL RESECTION; URETHRA STRICTURE; UROGENITAL TRACT TUMOR; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 26444442355     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-005-1416-5     Document Type: Article

References (24)

1. Coppin CM, Gospodarowisz MK, James K, et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1996;14:2901-7.
2. DeNeve W, Lybeert ML, Goor C, et al. Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Radiother Oncol 1995;36:183-8.
3. Diestelhorst A, Mueller AC, Kuehn R, et al. Organ sparing treatment of advanced bladder cancer: first experience with paclitaxel as alternative to cisplatin. Int J Radiat Oncol Biol Phys 2004;60:Suppl:435-6.
4. Dunst J, Rödel C, Schrott KM, et al. Bladder preservation in muscle-invasive bladder cancer by transurethral surgery and radiochemotherapy. Semin Surg Oncol 2001;20:24-32.
5. Given RW, Parsons JT, McCarley D, et al. Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a 5-year follow up. Urology 1995;46:499-505.
6. Gospodarowicz M. Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence? J Clin Oncol 2002;20:3048-50.
7. Hayter CR, Paszat LF, Groome PA, et al. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 1999;45:1239-45.
8. Housset M, Maulard C, Chretien YC, et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 1993;11:2150-7.
9. Kachnic LA, Kaufmann DS, Griffin PP, et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 1997;15:1022-9.
10. Kardamakis D, Hadjimichael C, Ginopoulos P, Papaioannou S. Effects of paclitaxel in combination with ionizing radiation on angiogenesis in the chick embryo chorioallantoic membrane. A radiobiological study. Strahlenther Onkol 2004;180:152-6.
11. Kim HL, Steinberg GD. The current status of bladder preservation in the treatment of muscle invasive bladder cancer. J Urol 2000;164:627-32.
12. Kuhnt T, Becker A, Pigorsch S, et al. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial. Strahlenther Onkol 2003;179:673-81.
13. Lovey J, Fazekas K, Ladanyi A, et al. Low-dose irradiation and short-exposure suboptimal-dose paclitaxel adversely modulate metastatic potential of squamous carcinoma cells. Strahlenther Onkol 2003;179:812-8.
14. Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003;21:690-6.
15. Moore MJ, O'Sullivan B, Tannock I. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1988;6:1736-45.
16. Rödel C. Current status of radiation therapy and combined modality treatment for bladder cancer. Strahlenther Onkol 2004;180:701-9.
17. Rödel C, Dunst J, Kühn R, et al. Organ-sparing treatment of advanced bladder cancer. J Clin Oncol 2002;20:3061-71.
18. Shipley WU, Prout GR Jr, Einstein AB, et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 1987;258:931-5.
19. Shipley WU, Zietman AL, Kaufman DS, et al. Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation. Int J Radiat Oncol Biol Phys 1997;39:937-43.
20. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19:666-75.
21. Tester W, Porter A, Asbell S, et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 1993;25:783-90.
22. Tester W, Porter A, Heaney J, et al. Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer. J Clin Oncol 1996;14:119-26.
23. Weiss C, Roedel F, Wolf I, et al. Combined modality treatment and organ preservation in bladder cancer: do molecular markers predict outcome? Strahlenther Onkol 2005;181:213-22.
24. Zietman AL, Shipley WU, Kaufman DS. The combination of cisplatinum-based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. Int J Radiat Oncol Biol Phys 1993;27:161-70.